Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

por Daud, A. I., Xu, C., Hwu, W.-J., Urbas, P., Andrews, S., Papadopoulos, N. E., Floren, L. C., Yver, A., DeConti, R. C., Sondak, V. K.
Publicado 2010

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

por Hamid, O, Robert, C, Daud, A, Hodi, F S, Hwu, W J, Kefford, R, Wolchok, J D, Hersey, P, Joseph, R, Weber, J S, Dronca, R, Mitchell, T C, Patnaik, A, Zarour, H M, Joshua, A M, Zhao, Q, Jensen, E, Ahsan, S, Ibrahim, N, Ribas, A
Publicado 2019